Prosecution Insights
Prosecution Insights
Technology area: Medical Devices & Mechanical Engineering
2 pending office actions • 1 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days
Cytrellis Biosystems Inc. currently manages 2 pending office actions within the Medical Devices & Mechanical Engineering technology area. These 2 actions are assigned to 2 distinct examiners, meaning each matter is being reviewed by a different individual. The prosecution is occurring within 1 distinct art unit, which suggests that the company's technology is concentrated in a single specialized examination group.
MCGRATH, ERIN E is the busiest examiner for the portfolio, holding 1 pending office action. This count of 1 is shared by the other distinct examiner involved in the 2 pending office actions. The presence of only 1 distinct art unit for 2 pending office actions indicates a high degree of technical focus. Practitioners must navigate the specific requirements of 2 different examiners while working within the same art unit in the Medical Devices & Mechanical Engineering sector. This focused environment may allow for more consistent prosecution strategies across the company's medical device filings.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Double-patenting + other | 1 (50%) |
| Multi-statute (no §101) | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| MCGRATH, ERIN E | 1 | 60.1% | +28.6% |
| DUBOSE, LAUREN | 1 | 60.1% | +43.3% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18560784 | SKIN TREATMENT SYSTEMS AND METHODS | DUBOSE, LAUREN | 35d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18560784 | SKIN TREATMENT SYSTEMS AND METHODS | DUBOSE, LAUREN | 35d overdue |
| 19214411 | DEVICES AND METHODS FOR COSMETIC SKIN RESURFACING | MCGRATH, ERIN E | — |
| Art Unit | Apps |
|---|---|
| 3771 | 2 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19214411 | DEVICES AND METHODS FOR COSMETIC SKIN RESURFACING | MCGRATH, ERIN E | 3771 | §103§112DP | Non-Final OA | — | Pending | May 21, 2025 |
| 18560784 | SKIN TREATMENT SYSTEMS AND METHODS | DUBOSE, LAUREN | 3771 | §102§112 | Non-Final OA | 35d overdue | Pending | Nov 14, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial